Stay updated with breaking news from Ainful Joint. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Almost all people who received in-hospital treatment for a gout flare were using urate-lowering therapy within 6 months of discharge after a multifaceted intervention with nurse-led follow-up.
European Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.
Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.
Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data.
The new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to more than one food.